Patient Adherence to Screening for Lung Cancer in the US: A Systematic Review and Meta-analysis
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Importance: To be effective in reducing deaths from lung cancer among high-risk current and former smokers, screening with low-dose computed tomography must be performed periodically. Objective: To examine lung cancer screening (LCS) adherence rates reported in the US, patient characteristics associated with adherence, and diagnostic testing rates after screening. Data Sources: Five electronic databases (MEDLINE, Embase, Scopus, CINAHL, and Web of Science) were searched for articles published in the English language from January 1, 2011, through February 28, 2020. Study Selection: Two reviewers independently selected prospective and retrospective cohort studies from 95 potentially relevant studies reporting patient LCS adherence. Data Extraction and Synthesis: Quality appraisal and data extraction were performed independently by 2 reviewers using the Newcastle-Ottawa Scale for quality assessment. A random-effects model meta-analysis was conducted when at least 2 studies reported on the same outcome. Reporting followed the Preferred Reporting Items for Systematic Review and Meta-analyses (PRISMA) guideline. Main Outcomes and Measures: The primary outcome was LCS adherence after a baseline screening. Secondary measures were the patient characteristics associated with adherence and the rate of diagnostic testing after screening. Results: Fifteen studies with a total of 16 863 individuals were included in this systematic review and meta-analysis. The pooled LCS adherence rate across all follow-up periods (range, 12-36 months) was 55% (95% CI, 44%-66%). Regarding patient characteristics associated with adherence rates, current smokers were less likely to adhere to LCS than former smokers (odds ratio [OR], 0.70; 95% CI, 0.62-0.80); White patients were more likely to adhere to LCS than patients of races other than White (OR, 2.0; 95% CI, 1.6-2.6); people 65 to 73 years of age were more likely to adhere to LCS than people 50 to 64 years of age (OR, 1.4; 95% CI, 1.0-1.9); and completion of 4 or more years of college was also associated with increased adherence compared with people not completing college (OR, 1.5; 95% CI, 1.1-2.1). Evidence was insufficient to evaluate diagnostic testing rates after abnormal screening scan results. The main source of variation was attributable to the eligibility criteria for screening used across studies. Conclusions and Relevance: In this study, the pooled LCS adherence rate after a baseline screening was far lower than those observed in large randomized clinical trials of screening. Interventions to promote adherence to screening should prioritize current smokers and smokers from minority populations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
(2014) · Medical Entomology and Zoology · Cited by 17,633
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064 · cited 1×
“Data Items When available, we captured the following: (1) general study information, such as title, authors, follow-up, year, funding agency, study design, setting (ie, academic or community), definition of adherence, geography (ie, rural or urban), hospital type (ie, safety net or federally qualified health center),…”
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial
de Koning, H. J., van der Aalst, C. M., de Jong, P. A., Scholten, E. T., Nackaerts, K., Heuvelmans, M. A., Lammers, J.-W. J., Weenink, C., Yousaf-Khan, U., Horeweg, N., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1911793 · Cited by 3,624 · cited 1×
“Data Items When available, we captured the following: (1) general study information, such as title, authors, follow-up, year, funding agency, study design, setting (ie, academic or community), definition of adherence, geography (ie, rural or urban), hospital type (ie, safety net or federally qualified health center),…”
MethodScreening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2014) · Annals of Internal Medicine · doi:10.7326/m13-2771 · Cited by 2,632
Humphrey, L. L., Deffebach, M., Pappas, M., Baumann, C., Artis, K., Mitchell, J. P., Zakher, B., Fu, R., & Slatore, C. G. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-6-201309170-00690 · Cited by 534
de Koning, H. J., Meza, R., Plevritis, S. K., ten Haaf, K., Munshi, V. N., Jeon, J., Erdogan, S. A., Kong, C. Y., Han, S. S., van Rosmalen, J., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m13-2316 · Cited by 466
Impact of provider-patient communication on cancer screening adherence: A systematic review
Peterson, E. B., Ostroff, J. S., DuHamel, K. N., D'Agostino, T. A., Hernandez, M., Canzona, M. R., & Bylund, C. L. (2016) · Preventive Medicine · doi:10.1016/j.ypmed.2016.09.034 · Cited by 308
Patterns and Trends in Cancer Screening in the United States
Hall, I. J., Tangka, F. K. L., Sabatino, S. A., Thompson, T. D., Graubard, B. I., & Breen, N. (2018) · Preventing Chronic Disease · doi:10.5888/pcd15.170465 · Cited by 279
Adherence with colorectal cancer screening guidelines: a review
Subramanian, S. (2004) · Preventive Medicine · doi:10.1016/j.ypmed.2003.12.011 · Cited by 261
Adherence and psychological adjustment among women at high risk for breast cancer
Lerman, C., & Schwartz, M. (1993) · Breast Cancer Research and Treatment · doi:10.1007/bf00666427 · Cited by 243
Understanding Current Racial/Ethnic Disparities in Colorectal Cancer Screening in the United States
Liss, D. T., & Baker, D. W. (2014) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2013.10.023 · Cited by 232 · cited 1×
“(%) Pack-years, mean (SD) Eligibility criteria Alshora et al,12 2018 Range, 50-74 503 (56) >95% White Not reported 414 (46) Not reported NCCN guidelinesa”
BackgroundTammemagi, M. C., Schmidt, H., Martel, S., McWilliams, A., Goffin, J. R., Johnston, M. R., Nicholas, G., Tremblay, A., Bhatia, R., Liu, G., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30597-1 · Cited by 216
Damiani, G., Basso, D., Acampora, A., Bianchi, C. B. N. A., Silvestrini, G., Frisicale, E. M., Sassi, F., & Ricciardi, W. (2015) · Preventive Medicine · doi:10.1016/j.ypmed.2015.09.011 · Cited by 214
Lung cancer screening: what do long‐term smokers know and believe?
Carter‐Harris, L., Ceppa, D. P., Hanna, N., & Rawl, S. M. (2017) · Health Expectations · doi:10.1111/hex.12433 · Cited by 187
Multilevel Opportunities to Address Lung Cancer Stigma across the Cancer Control Continuum
Hamann, H. A., Ver Hoeve, E. S., Carter-Harris, L., Studts, J. L., & Ostroff, J. S. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.05.014 · Cited by 183 · cited 1×
“Porubcin et al,20,21 2015, 2017 Median, 64b; range, 55-80 234 (50) Not reported Not reported Not reported ≥30 Ages 55-80 y, ≥30–pack-year smoking history, including former smokers who had quit within 15 y Sakoda et al,22 2018 Median, 66b 88 (61) White (n = 103) Conducted within Kaiser Permanente 110 (76) Not reported…”
Huo, J., Shen, C., Volk, R. J., & Shih, Y.-C. T. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.9016 · Cited by 113 · cited 1×
“Porubcin et al,20,21 2015, 2017 Median, 64b; range, 55-80 234 (50) Not reported Not reported Not reported ≥30 Ages 55-80 y, ≥30–pack-year smoking history, including former smokers who had quit within 15 y Sakoda et al,22 2018 Median, 66b 88 (61) White (n = 103) Conducted within Kaiser Permanente 110 (76) Not reported…”
Self-citationCarter‐Harris, L., Slaven, J. E., Monahan, P. O., Shedd-Steele, R. B., Hanna, N. H., & Rawl, S. M. (2018) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2018.01.018 · Cited by 111 · cited 1×
“Porubcin et al,20,21 2015, 2017 Median, 64b; range, 55-80 234 (50) Not reported Not reported Not reported ≥30 Ages 55-80 y, ≥30–pack-year smoking history, including former smokers who had quit within 15 y Sakoda et al,22 2018 Median, 66b 88 (61) White (n = 103) Conducted within Kaiser Permanente 110 (76) Not reported…”
Breast Cancer Screening Adherence: Does Church Attendance Matter?
Fox, S. A., Pitkin, K., Paul, C., Carson, S., & Duan, N. (1998) · Health Education & Behavior · doi:10.1177/109019819802500605 · Cited by 108 · cited 2×
“Plank et al,19 2018 Mean, 60 495 (60) Not reported NA 347 (42) 46 (24) NCCN guidelinesa”
BackgroundCancer Screening Patterns Among Current, Former, and Never Smokers in the United States, 2010-2015
Sanford, N. N., Sher, D. J., Butler, S. S., Xu, X., Ahn, C. W., D'Amico, A. V., Rebbeck, T. R., Aizer, A. A., & Mahal, B. A. V. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.3759 · Cited by 82
Racial differences in PSA screening interval and stage at diagnosis
Carpenter, W. R., Howard, D. L., Taylor, Y. J., Ross, L. E., Wobker, S. E., & Godley, P. A. (2010) · Cancer Causes & Control · doi:10.1007/s10552-010-9535-4 · Cited by 78
Eberth, J. M., McDonnell, K. K., Sercy, E., Khan, S., Strayer, S. M., Dievendorf, A. C., Munden, R. F., & Vernon, S. W. (2018) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2018.05.013 · Cited by 72
Dealing with missing outcome data in meta‐analysis
Mavridis, D., & White, I. R. (2020) · Research Synthesis Methods · doi:10.1002/jrsm.1349 · Cited by 65
Lam, A. C. L., Aggarwal, R., Cheung, S., Stewart, E., Darling, G. E., Lam, S. C., Xu, W., Liu, G., & Kavanagh, J. (2020) · Lung Cancer · doi:10.1016/j.lungcan.2020.05.013 · Cited by 64 · cited 1×
“Bhandari et al,13 2019 Median, 64 2070 (46) Not reported Not reported 3105 (69) 52 All lung cancer screening patients within a Kentucky health system Brasher et al,14 2018 Mean, 66b; range, 55-80 Not reported Not reported Conducted within VA Not reported Not reported Ages 55-80 y, ≥30–pack-year smoking history, includ…”
BackgroundDeterminants of Breast, Cervical and Colorectal Cancer Screening Adherence in Mexican–American Women
González, P., Castañeda, S. F., Mills, P. J., Talavera, G. A., Elder, J. P., & Gallo, L. C. (2011) · Journal of Community Health · doi:10.1007/s10900-011-9459-2 · Cited by 60
Adams, S. A., Choi, S. K., Khang, L., Campbell, D. A., Friedman, D. B., Eberth, J. M., Glasgow, R. E., Tucker‐Seeley, R. D., Xirasagar, S., Yip, M.-P., et al. (2015) · Journal of Community Health · doi:10.1007/s10900-014-9978-8 · Cited by 58
Screening Adherence in the Veterans Administration Lung Cancer Screening Demonstration Project
Tanner, N. T., Brasher, P. B., Wojciechowski, B., Ward, R. C., Slatore, C. G., Gebregziabher, M., & Silvestri, G. A. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.04.063 · Cited by 58
Kessler, T. A. (2011) · Oncology nursing forum · doi:10.1188/12.onf.61-68 · Cited by 53
Kaminetzky, M., Milch, H. S., Shmukler, A., Kessler, A., Peng, R. Y., Mardakhaev, E., Bellin, E. Y., Levsky, J. M., & Haramati, L. B. (2018) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2018.07.011 · Cited by 49
Miranda, P. Y., Tarraf, W., & González, H. M. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1367-8 · Cited by 46 · cited 2×
“6) Reminder: 116 (57) Reminder: White (n = 172), no reminder: White (n = 42) Reminder: government (n = 151), private (n = 49), other (n = 5) Reminder: 113 (55) Reminder: 48.”
Trends in Adherence to Recommended Cancer Screening: The US Population and Working Cancer Survivors
Clarke, T. C., Soler‐Vilá, H., Fleming, L. E., Christ, S. L., Lee, D. J., & Arheart, K. L. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00190 · Cited by 45
Opportunities for Improving Cancer Prevention at Federally Qualified Health Centers
Allen, C. L., Harris, J. R., Hannon, P. A., Parrish, A. T., Hammerback, K., Craft, J., & Gray, B. (2013) · Journal of Cancer Education · doi:10.1007/s13187-013-0535-4 · Cited by 42
Hubbard, R. A., O’Meara, E. S., Henderson, L. M., Hill, D. A., Braithwaite, D., Haas, J. S., Lee, C. I., Sprague, B. L., Alford‐Teaster, J., Tosteson, A. N. A., et al. (2016) · Preventive Medicine · doi:10.1016/j.ypmed.2016.05.034 · Cited by 41
Cardarelli, R., Reese, D. R., Roper, K. L., Cardarelli, K., Feltner, F. J., Studts, J. L., Knight, J. R., Armstrong, D. K., Weaver, A. D., & Shaffer, D. C. (2016) · Cancer Epidemiology · doi:10.1016/j.canep.2016.11.003 · Cited by 39 · cited 3×
“(%) Pack-years, mean (SD) Eligibility criteria Alshora et al,12 2018 Range, 50-74 503 (56) >95% White Not reported 414 (46) Not reported NCCN guidelinesa”
BackgroundPatient Reminders and Longitudinal Adherence to Lung Cancer Screening in an Academic Setting
Hirsch, E. A., New, M. L., Brown, S., Barón, A. E., & Malkoski, S. P. (2019) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201902-152rl · Cited by 36
Paynter, C. A., Treeck, B. J. V., Verdenius, I., Lau, A., Dhawan, T., Lash, K. A., Bergamini, E. A., Ekekezie, C., Hilal, A. M., James, K. N., et al. (2015) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2015.07.011 · Cited by 27
Racial/ethnic differences in screening for colon cancer: report from the New York Cancer Project.
Vlahov, D., Ahern, J., Vazquez, T., Johnson, S., Philips, L. A., Nash, D., Mitchell, M. K., & Freeman, H. P. (2005) · PubMed · Cited by 27
Brasher, P. B., Tanner, N. T., Yeager, D. E., & Silvestri, G. A. (2018) · CHEST Journal · doi:10.1016/j.chest.2018.08.576 · Cited by 12
Metadata
- Authors
- Lopez-Olivo, M. A., Maki, K. G., Choi, N. J., Hoffman, R. M., Shih, Y.-C. T., Lowenstein, L. M., Hicklen, R. S., & Volk, R. J.
- Venue
- JAMA Network Open
- Publisher
- American Medical Association (AMA)
- Published
- 2020-11-16
- Volume
- 3
- Issue
- 11
- Pages
- e2025102
- ISSN
- 2574-3805 (ISSN-L)
- OpenAlex
- W3100840451
- Cited by
- 187
- References
- 39
- FWCI
- 10.47
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.